The Egyptian Journal of Haematology
Table of Contents

2012| October | Volume 37 | Issue 4
Please wait, loading Google Map...
ORIGINAL ARTICLES | ||
Lipid profile in children with β-thalassemia major | p. 183 | |
Samera Z. Sayed, Sheren E. Maher, Ghada Adel, Lamea Hamdy | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Role of adiponectin in chronic lymphocytic leukemia | p. 187 |
Hosneia K. Akl, Tarek M. Elgohary | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
CD64 ( diagnostic accuracy compared with the hematologic scoring system and CRP in neonatal sepsis) | p. 193 |
Hanan E. Mohamed, Hosneia K. Akl, Ehab A. El Banna | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
Nucleophosmin (NPM1-A) and FMS-like tyrosine kinase 3 (FLT3/ITD) mutations in acute myeloid leukaemia with a normal karyotype ( frequency and prognostic significance) | p. 200 | |
Hosneia K.H. Akl, Heba H Gawish, Fouad M Abou Taleb | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Expression of myelomonocytic antigens in Egyptian B-cell chronic lymphocytic leukemia ( impact on prognosis) | p. 207 |
Deena M.M. Habashy, Amira F. Barakat | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Polysomy 8 in Egyptian patients with de-novo acute myeloid leukemia | p. 213 |
Tahany Ali El Kerdany, Hesham Fayek Kayed, Abeer Attia Saad, Shaymaa Salah El-Dine El-Gaafary, Nevine Nabil Moustafa | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
The impact of CLLU1 expression as a prognostic marker in chronic lymphocytic leukemia | p. 221 |
Maha Atfy, Tarek El-Gohary | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Detection of insulin-like growth factor type I receptor in adulthood acute lymphoblastic leukemia by a real-time polymerase chain reaction | p. 228 |
Hebatallah Adel Sedky, Dina Adel Fouad, Deena Mohamed Mohamed Habashy, Nisreen Atef Abdel Ghaffar | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Treatment of early-stage Hodgkin’s lymphoma outcome ( Kuwait experience) | p. 234 |
Rehab S. ElHagracy, Salem H. AlShemmari, Amany Elbassmy | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Prognostic significance of serum monoclonal immunoglobulin in B-chronic lymphocytic leukemia | p. 240 |
Mona A. El-Hussiny, Lamiaa Ibrahim, Emad Azmy, Sameh Shamaa | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Study of transcription factor CCAAT/enhancer binding protein-α (C/EBPα) in adult patients with acute lymphoblastic leukemia | p. 246 |
Inas A. Asfour, Rehab S. Elhagracy, Gihan M. Kamal, Nermeen A. Nabih, Amal A. Abass, Rania A. Radwan | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Role of P53 deletion in patients with acute myeloid leukaemia | p. 252 |
Mona A. Ismail, Tamer M. Ahmed, Iman Z. Ahmed | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
The percentage of deletion of the B-cell neoplasia-associated gene with multiple splicing ( an indicator for the prognosis of CLL) | p. 257 |
Nahela A. Shalaby, Dina A. Fouad, Doaa G. Eissa, Rasha I. Ibrahim | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
The reliability of endothelial progenitor cells (CD34+, KDR+, and CD34+/KDR+) in the diagnosis of coronary artery disease and its severity | p. 262 |
Eman M. Sewify, Ola Afifi, Mona M. Soliman, Ahmad I. Ziada | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Cyclin D1 gene amplification in multiple myeloma and its impact on the disease outcome and drug resistance | p. 268 |
Eman M. Sewify, Ola A. Afifi, Eman Mosad, Amen Hamdy Zaki | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Expression of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 in childhood acute lymphoblastic leukemia | p. 274 |
Mohamed A. Mekawy, Sahar S. Abdel Maksoud, Doaa G. Eissa, Abeer A. Abdelmaksoud, Iman A. Ragab, Mahmoud T. Sallam, Adam A. Yousef | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Assessment of placental growth factor and soluble vascular endothelial growth factor receptor 1 in the prediction of pre-eclampsia | p. 281 |
Maha Basuni, Waleed M. Fathy, Wail Gaber | ||
[ABSTRACT] [HTML Full text] [PDF] | ||
![]() |
Therapeutic decision analysis for monitoring UFH therapy using activated partial thromboplastin time compared with anti-Xa assay | p. 287 |
Zinab Mourad, Wafaa El-Neanaey, Wael Shaalan, Mohamed A. Faghry | ||
[ABSTRACT] [HTML Full text] [PDF] | ||